Sanofi Was Mystery Bidder That Lost Reata to Biogen 

Hedge Funds Turned Long Aussie Dollar at Just the Wrong Time

China’s Economic Woes Deepen With Housing Market Slump

Yellow Sees Even More Interest From Lenders for Bankruptcy Financing

Sliding Aussie Seen Stoking Prices as Shock-Absorber Fades

RBA’s Lowe Keeps Door Open to Further Hike, Eyes Services Prices

Tainted Medication Fears Spur US Defense Department to Seek Outside Testing

A $2.8 Million Miracle Therapy Eludes Some Long-Suffering Patients

Australian Consumer Sentiment Slips as Price Pressures Mount

Elon Musk's Neuralink Raises $280 Million to Develop Brain Implants

Sage Tumbles as Depression Pill Approval Omits Major Disorder

Astellas Pharma Secures US FDA Approval for Izervay